Search results for "Migraine"


 
Results 1 - 10 of about 193 for "Migraine".
Sort by: Relevance | Newest | Oldest

Ubrogepant appears effective for early acute treatment of migraine

An industry-funded trial found that ubrogepant was associated with absence of moderate or severe headache within 24 hours 46% of the time versus 29% with placebo when taken during the prodrome period (nonaura symptoms preceding headache onset).
https://immattersacp.org/weekly/archives/2023/11/21/2.htm
21 Nov 2023

Sorting out vertigo

A shift in diagnostic approach for vertigo involves asking about the timing and triggers for episodes rather than a description of symptoms.
https://immattersacp.org/archives/2024/01/sorting-out-vertigo.htm
1 Jan 2024

Talking about migraines

Collecting good data is the first step in sorting through the many drugs and devices that are used to treat migraines.
https://immattersacp.org/archives/2019/07/talking-about-migraines.htm
1 Jul 2019

Migraine studies find new drug, several existing options all effective for acute treatment

An industry-funded trial found that migraine pain resolved sooner with eptinezumab than placebo, while a meta-analysis found that several established and newer therapies for the acute treatment of migraine were associated with reductions in short-term pain.
https://immattersacp.org/weekly/archives/2021/06/22/5.htm
22 Jun 2021

Set expectations for new migraine treatments

New drugs take aim at migraine prevention, but long-term effects are uncertain.
https://immattersacp.org/archives/2018/10/set-expectations-for-new-migraine-treatments.htm
1 Oct 2018

Similar improvements in migraine frequency seen with mindfulness meditation vs. headache education

While mindfulness-based stress reduction did not improve migraine frequency more than headache education in a small randomized trial, it significantly improved disability, quality of life, self-efficacy, pain catastrophizing, and depression out to 36 weeks.
https://immattersacp.org/weekly/archives/2020/12/22/6.htm
22 Dec 2020

Erenumab reduced migraines in patients who didn't respond to other treatments, industry-funded study found

An industry-funded study found improvements in primary and secondary endpoints related to migraines with the drug compared to placebo, with similar safety and tolerability.
https://immattersacp.org/weekly/archives/2018/10/30/4.htm
30 Oct 2018

Handling the hassle of administrative hurdles

CMS released a proposed rule to address the administrative hassles of prior authorizations in Medicare Advantage plans, calling for automated processes, shorter decision-making time frames, and more transparency about the services subject to prior authorizations.
https://immattersacp.org/archives/2023/11/handling-the-hassle-of-administrative-hurdles.htm
1 Nov 2023

Migraine associated with cardiovascular risks

Higher absolute risks of cardiovascular disease were observed among patients with migraine across most outcomes and follow-up periods during 19 years of follow-up.
https://immattersacp.org/weekly/archives/2018/02/06/4.htm
6 Feb 2018

Tirzepatide for weight management, at-home STI tests

This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2024/01/tirzepatide-for-weight-management-at-home-sti-tests.htm
1 Jan 2024

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next